Herbal formulations being widely accepted therapeutic agents as antidiabetics, antiarthritics, hepatoprotectives, cough remedies, memory enhancers, and adaptogens. The commonest myth regarding herbal medicines is that these medicines are completely safe, and can therefore be safely consumed by the patient on his/her own, without a physician's prescription. This belief has led to large-scale self-medication by people all over the world, often leading to disappointing end-results, side-effects, or unwanted after-effects. There is an increasing awareness at several levels of the need to develop pharmacovigilance practices for herbal medicines. The current model of pharmacovigilance and its associated tools have been developed in relation to synthetic drugs, and applying these methods to monitoring the safety of herbal medicines presents unique challenges in addition to those described for conventional medicines. Several problems relate to the ways in which herbal medicines are named, perceived, sourced, and utilized. This may be because of differences in the use of nonorthodox drugs (e.g., herbal remedies) which may pose special toxicological problems, when used alone or in combination with other drugs. The purpose of pharmacovigilance is to detect, assess, and understand, and to prevent the adverse effects or any other possible drug-related problems, related to herbal, traditional, and complementary medicines. Key words: Adverse reaction, herbal medicines, pharmacovigilance.

Renin inhibitors are antihypertensive drugs that block the first step in the renin-angiotensin system. Their mechanism of action differs from that of the angiotensin-converting enzyme inhibitors and angiotensin-receptor antagonists, but like these drugs, renin inhibitors interrupt the negative feedback effects of angiotensin II on renin secretion. The renin–angiotensin–aldosterone system (RAAS) has long been recognized to play a significant role in hypertension pathophysiology. Certain agents that modify the RAAS can control blood pressure and improve cardiovascular outcomes. Optimization of this compound by Novartis led to the development of aliskiren – the only direct renin inhibitor which is clinically used as an antihypertensive drug. Aliskiren is the first of a new class of antihypertensive agents. Aliskiren is a new renin inhibitor of a novel structural class that has recently been shown to be efficacious in hypertensive patients after once-daily oral dosing. In short-term studies, it was effective in lowering blood pressure either alone or in combination with valsartan and hydrochlorothiazide, and had a low incidence of serious adverse effects. It was approved by the Food and Drug Administration in 2007 for the use as a monotherapy or in combination with other antihypertensives. Greater reductions in blood pressure have been achieved when aliskiren was used in combination with hydrochlorothiazide or an angiotensin-receptor blocker. The most common adverse effects reported in clinical trials were headache, fatigue, dizziness, diarrhea, and nasopharyngitis. Aliskiren has not been studied in patients with moderate renal dysfunction; as an RAAS-acting drug, it should be prescribed for such patients only with caution.

Myasthenia gravis is an autoimmune disorder caused by antibodies that attack the neuromuscular junction. These antibodies target and damage postsynaptic components by binding to the postsynaptic muscle end-plate, leading to disrupted signal transmission and resulting in muscle weakness and fatigue. Advances in understanding the immunological mechanisms behind myasthenia gravis have led to the development of targeted immunotherapies. This review examines the subgroups of myasthenia gravis, therapeutic advances, and the impact of myasthenia gravis on pregnancy and its management. While many patients with myasthenia gravis experience mild to moderate symptoms and manage the condition well, the focus now is on developing therapies that either minimize or enhance tolerance to the specific autoimmune responses that cause the production of autoimmune antibodies and muscle weakness. Certain medications commonly used in obstetrics can worsen the condition. The effects of pregnancy on myasthenia gravis can vary significantly from woman to woman and between pregnancies in the same individual. Common treatments include acetylcholinesterase inhibitors, corticosteroids, immunosuppressants, and proper rest. In some cases, intrauterine exposure to antibodies can lead to temporary effects in newborns.

The review gives a brief about PCOS and the symptoms related to the disease. Around 2.2 to 26% of cases of PCOS are present globally. The disorder generally occurs in the reproductive age group of women. The review has a mention of few herbs which can be used to correct the diseased condition. The various herbs have a positive effect on the diseased condition and can be used to cure symptoms like hypothyroidism, hyperplasia, obesity, diabetes, Menorrhagia, sleep disturbances, cardiovascular problems, hyperlipidemia, hirsutism, infertility, irregular menstrual cycle, etc. The search engines used are PubMed, various review articles, etc. The method involved in the review includes various medicinal herbs that have been seen to affect women having various gynecological disorders like Poly Cystic Ovarian Syndrome, Uterine Fibroids, and Endometriosis. The herbs included in the review include Bauhinia variegata useful in hormone imbalance, Phyllanthus emblica, Terminalia bellirica, Terminalia chebula, and Commiphora wightii are used to regulate the hormones, Cinnamon cassia acts as an anti-oxidant, Tribulus terrestris improves reproductive dysfunction, Hypericum perforatum regulates depression, Commiphora myrrha prevents menorrhagia, Nigella sativa controls cholesterol, Saraca asoca has estrogenic action, Asparagus racemosus promotes folliculogenesis, Tinospora cordifolia regulates menstrual flow, Ocimum sanctum as an anti-oxidant. The plants taken had a positive effect on women with PCOS without causing any side effects. The natural herbs used for the treatment of PCOS did not have any side effects and treated the diseased condition naturally. This review aims to understand the natural plants available for the treatment of the disease naturally. The herbs can be used individually or can be used in combination.

Background: Dandruff is a major problem of hair, which cannot be fully cured with the aid of chemicals. An attempt has been made to prepare a poly-herbal anti-dandruff hair care formulation and it is standardized to ensure its stability and quality aspects. Objective: The present work is oriented at the synthesis of herbal anti-dandruff hair formulation and the estimation of its various aspects for its valuability. Materials and Methods: The herbal preparation was prepared in the laboratory, on the basis of decided proportion, with the help of all the herbal contents. The pack was gauged for its various parameters. Results: The results were concluded to be sufficiently ample for the assessment of herbal formulation. The findings of different aspects vindicated the worth of the formulation. Conclusion: Herbal hair formulation has been formulated and assessed using the various aspects. It serves as a good alternate, devoid of any side effects. The results can be unified while evolving the pharmacopoeial standards.

Background: The existence of aberrant myocardial activity and function in the exclusion of those other cardiovascular events, such as atherosclerosis, hypertension, and severe valve disease, is known as diabetic cardiomyopathy. Diabetes patients are much more prone to death from cardiovascular illnesses than from any other cause, and they also have a 2–5 fold higher likelihood of acquiring cardiac failure and other complications. Objective: In this review, the pathophysiology of diabetic cardiomyopathy is discussed, with an emphasis on the molecular and cellular irregularities that arise as the condition progresses, as well as existing and prospective future treatments. Method: The literature for this topic was researched utilizing Google Scholar as a search engine. Before compiling the review article, several research and review publications from various publishers, including Bentham Science, Nature, Frontiers, and Elsevier, were investigated. Result: The abnormal cardiac remodelling, marked by left ventricular concentric thickening and interstitial fibrosis contributing to diastolic impairment, is mediated by hyperglycemia, and insulin sensitivity. The pathophysiology of diabetic cardiomyopathy has been linked to altered biochemical parameters, decreased calcium regulation and energy production, enhanced oxidative damage and inflammation, and a build-up of advanced glycation end products. Conclusion: Antihyperglycemic medications are essential for managing diabetes because they successfully lower microvascular problems. GLP-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors have now been proven to benefit heart health by having a direct impact on the cardiomyocyte. To cure and avoid diabetic cardiomyopathy new medicines are being researched, including miRNA and stem cell therapies.